Business Development in Life Sciences Is a Volume Game
Life sciences business development is a discipline where volume and speed directly determine outcomes. The most active BD teams at pharma and biotech companies evaluate dozens of potential partnerships, licensing opportunities, and acquisition targets each year. Every evaluation generates a confidentiality disclosure agreement (CDA), at least one or two partner meetings, a data room disclosure process, and a term sheet or pass decision.
According to a 2025 report by Evaluate Pharma, global pharma and biotech licensing deal volume reached a record 1,847 signed transactions in 2024 — a 19% increase over 2022 levels. BD teams that can move faster through the evaluation and diligence process close more deals on better terms. Teams that are slowed by administrative drag — lost CDA versions, missed meeting prep, disorganized data rooms — lose opportunities to better-organized competitors.
Virtual assistants trained in life sciences BD operations are helping teams move faster by owning the administrative infrastructure behind every active deal opportunity.
CDA Management: More Complex Than It Looks
A confidentiality disclosure agreement is the gateway document for any BD engagement — nothing substantive can be discussed without one in place. For a BD team actively evaluating 30–50 opportunities at any given time, CDA management is a significant ongoing administrative task.
CDAs require negotiation, execution, filing, and expiration tracking. When a CDA expires on an ongoing engagement, the parties are technically operating without confidentiality protection — a risk that BD teams frequently fail to monitor when managing high volumes of active relationships.
A virtual assistant managing the CDA workflow can:
- Maintain the CDA tracker — a master log of all active CDAs by counterparty, execution date, term length, and expiration date, with automated reminder alerts for upcoming expirations
- Coordinate CDA routing and execution through DocuSign or equivalent e-signature platforms, tracking signature status and sending reminders to counterparties
- Manage CDA version control during negotiation — maintaining a redline log and routing revised versions to legal counsel and the BD lead
- Archive executed CDAs in the secure deal management system, indexed by company, program, and date
- Monitor CDA renewal requirements for ongoing partnership discussions that extend beyond the original term
A structured CDA management system maintained by a VA prevents the common BD failure mode of discovering an expired agreement mid-diligence — often at a critical deal juncture.
Partner Meeting Preparation
BD partner meetings — whether initial introductions, follow-on scientific discussions, or term sheet negotiations — require preparation packages that typically include a company/program overview brief, prior meeting notes, outstanding due diligence questions, and logistical coordination across multiple time zones.
Preparing for three or four partner meetings in a single week is a significant coordination task for a BD team already focused on relationship management and deal strategy. Virtual assistants can own the preparation layer by:
- Preparing meeting briefing packages — pulling the counterparty's recent news, publication activity, pipeline updates, and prior meeting notes into a standardized prep document
- Scheduling meetings across internal and external participants, managing calendar conflicts and time zone coordination
- Preparing the internal pre-meeting agenda and circulating it to the BD team 24 hours in advance
- Distributing NDAs, meeting access links, and logistical details to external participants
- Capturing and distributing post-meeting notes from the BD lead's dictated summary, formatted for the deal file
- Tracking follow-up commitments made in meetings — requests for data packages, term sheet timelines, and technical questions requiring response
Virtual Data Room Management
The virtual data room (VDR) is the center of gravity for due diligence in any licensing or M&A transaction. Organizing, maintaining, and managing access to the VDR is a time-consuming task that can consume hours of senior BD staff time when poorly delegated.
A virtual assistant managing VDR operations can:
- Set up and maintain the VDR structure according to the BD team's standard disclosure index, uploading documents as they are cleared for release
- Manage counterparty access permissions — provisioning user accounts, tracking who has accessed which documents, and removing access upon deal termination
- Maintain the VDR document log — tracking upload date, document version, and access status for each item in the room
- Coordinate document clearing requests with legal and regulatory teams when counterparties request materials not yet in the room
- Generate VDR activity reports for the deal team — showing which counterparties are actively reviewing the room and which sections are drawing the most interest
Activity patterns in the VDR provide deal intelligence — a highly engaged counterparty reviewing manufacturing data and commercial forecasts is further along in their evaluation than one browsing scientific summaries. VA-maintained activity reports surface that intelligence systematically.
Competitive Advantage Through Operational Discipline
The most successful BD teams in life sciences are operationally disciplined as well as scientifically and commercially sharp. VAs who own the CDA, meeting prep, and data room coordination layer allow senior dealmakers to stay focused on the relationship and strategy work that actually moves transactions forward.
Stealth Agents provides virtual assistants with life sciences business development administrative experience who can be integrated into BD team workflows and deployed across CDA management, meeting coordination, and deal room operations.
Sources
- Evaluate Pharma, Global Pharma & Biotech Licensing Deal Volume Report, 2025
- Informa Pharma Intelligence, Business Development Benchmarking Survey, 2024
- Association of University Technology Managers (AUTM), Licensing Activity Survey, 2024
- ICLG, Pharmaceutical Advertising and Licensing Laws: Key Considerations for Life Sciences BD, 2025